Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1979 Feb;41(2):192–198. doi: 10.1136/hrt.41.2.192

Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.

G Koch
PMCID: PMC486851  PMID: 106867

Full text

PDF
192

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atterhög J. H., Dunér H., Pernow B. Haemodynamic effects of pindolol in hypertensive patients. Acta Med Scand Suppl. 1977;606:55–62. doi: 10.1111/j.0954-6820.1977.tb18030.x. [DOI] [PubMed] [Google Scholar]
  2. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Labetalol: a review of its pharmacology and therapeutic use in hypertension. Drugs. 1978 Apr;15(4):251–270. doi: 10.2165/00003495-197815040-00002. [DOI] [PubMed] [Google Scholar]
  3. Koch G. Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients. Am Heart J. 1977 May;93(5):585–591. doi: 10.1016/s0002-8703(77)80008-2. [DOI] [PubMed] [Google Scholar]
  4. Koch G. Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):729–732. [PubMed] [Google Scholar]
  5. Koch G. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combination of beta-receptor blocking and vasodilator agent. Br Heart J. 1976 Dec;38(12):1240–1246. doi: 10.1136/hrt.38.12.1240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Koch G. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):725–728. [PubMed] [Google Scholar]
  7. Koch G. Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation. Arzneimittelforschung. 1971 Jan;21(1):57–61. [PubMed] [Google Scholar]
  8. Lund-Johansen P., Ohm O. J. Haemodynamic long-term effects of beta-receptor-blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol. Clin Sci Mol Med Suppl. 1976 Dec;3:481S–483S. doi: 10.1042/cs051481s. [DOI] [PubMed] [Google Scholar]
  9. Majid P. A., Meeran M. K., Benaim M. E., Sharma B., Taylor S. H. Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension. Br Heart J. 1974 Jun;36(6):588–596. doi: 10.1136/hrt.36.6.588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tarazi R. C., Dustan H. P. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol. 1972 May;29(5):633–640. doi: 10.1016/0002-9149(72)90164-6. [DOI] [PubMed] [Google Scholar]
  11. Weiss L., Lundgren Y., Folkow B. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR). Acta Physiol Scand. 1974 Aug;91(4):447–457. doi: 10.1111/j.1748-1716.1974.tb05701.x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES